Matthew Simpson is a seasoned professional with extensive experience in strategic marketing and product management within the healthcare sector, currently serving as Sr. Director of US Region Strategic Marketing at BD since June 2016. Previous roles at The Medicines Company included Director of New Products Planning, where Matthew led the commercial strategy and launch of IONSYS® in postoperative pain, and Manager of Global Chest Pain Pathway, responsible for the successful management of Angiomax®, generating significant revenue. Matthew's early career involved coordinating clinical trials and project management, with research experience gained at the University of Texas Marine Science Institute and Virginia Tech. Educational credentials include an MBA from NYU Stern School of Business and a Bachelor's degree in Biology, Chemistry, and Spanish from Virginia Tech.
This person is not in any teams
This person is not in any offices